Virax is an Australian biotechnology company developing immune based therapies that direct the immune system to treat disease. The Company is dedicated to developing a new class of immunotherapeutics to treat widespread, life-threatening diseases of the immune system including HIV/AIDS and other infectious diseases, cancers and autoimmune disease.